TLS treatment significantly abrogated CBD-induced apoptosis in CR NSCLC cells (Figure 6C,D) in addition to CBD-induced activation of the apoptosis markers, caspase 3 and 9 (Figure 6E–H and Figure S4). The gene discussed is CASP3; the disease is non-small cell lung carcinoma.